Kura jumps on narrower-than-expected quarterly loss
13/08/2026 15:54
BUZZ-Kura jumps on narrower-than-expected quarterly loss ** Shares of drugmaker Kura Oncology KURA.O rise 10.4% to $10.99
** Co reports Q2 loss of 77 cents/shr vs analysts' average loss estimate of 88 cents/shr, according to LSEG data
** KURA reports R&D expense of $61.9 million for the quarter compared to analysts' average estimate of $67.5 million
** Co generates $9.1 million in Q2 net product revenue, up 57% over Q1, on sales of its blood cancer drug Komzifti
** Says 115 new patients started on Komzifti in Q2, up 35% over the first-quarter
** "We believe the increase in new patient starts indicated growing physician preference for Komzifti over competition" says Wedbush analyst Robert Driscoll
** Including session's move, stock up 6% YTD
(Reporting by Christy Santhosh)